Canna~Fangled Abstracts

Cannabinoids, their cellular receptors, and effects on the invasive phenotype of carcinoma and metastasis

By July 26, 2021July 28th, 2021No Comments
Review

doi: 10.1002/cnr2.1475.

Online ahead of print.
Affiliations 

Abstract

Background: The morbidity and mortality of cancer are significantly impacted by the invasive and metastatic potential of particular subgroups of malignant cells within a tumor. The particular pre-metastatic properties of cancerous cells are thus a critical target for novel therapeutics in the oncology field. Cannabinoid molecules have been investigated in recent years in the context of invasion and metastasis of various malignancies, with varying effects reported in the literature.

Recent findings: There was substantial variability in the findings reported by the literature of the effects of cannabinoid molecules on cancer cell invasion and metastasis. These effects varied depending on which ligand and which of the CB1, CB2, or GPR55 receptors were investigated. These findings suggest a role for the phenomenon of biased signaling in explaining the diversity of effects of cannabinoid molecules on cancer cell invasion.

Conclusion: While substantially more investigation is required into the effects of cannabinoid molecules on cancer cell invasion and metastasis, we describe in this review the significant diversity in the responses of cancer cells to cannabinoid molecules in terms of their invasive and metastatic capacities.

 

Keywords: CB1, CB2, GPR55, biased signaling, cannabinoids, invasion

References

REFERENCES

    1. Seyfried TN, Huysentruyt LC. On the origin of cancer metastasis. Crit Rev Oncog. 2013;18(1-2):43-73. https://doi.org/10.1615/critrevoncog.v18.i1-2.40
    1. Dillekås H, Rogers MS, Straume O. Are 90% of deaths from cancer caused by metastases? Cancer Med. 2019;8(12):5574-5576. https://doi.org/10.1002/cam4.2474
    1. Carter GT, Flanagan AM, Earleywine M, Abrams DI, Aggarwal SK, Grinspoon L. Cannabis in palliative medicine: improving care and reducing opioid-related morbidity. Am J Hosp Palliat Care. 2011;28(5):297-303. https://doi.org/10.1177/1049909111402318
    1. Atwood BK, Wager-Miller J, Haskins C, Straiker A, Mackie K. Functional selectivity in CB2 cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB2 ligands. Mol Pharmacol. 2012;81(2):250-263. https://doi.org/10.1124/mol.111.074013
    1. Luo H, Rossi E, Saubamea B, et al. Cannabidiol increases proliferation, migration, tubulogenesis, and integrity of human brain endothelial cells through TRPV2 activation. Mol Pharm. 2019;16(3):1312-1326. https://doi.org/10.1021/acs.molpharmaceut.8b01252

Publication types

Leave a Reply